BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35049881)

  • 1. Semi-Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationships of Brefeldin A Derivatives with Antileukemia Activity.
    Lu XX; Jiang YY; Wu YW; Chen GY; Shao CL; Gu YC; Liu M; Wei MY
    Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brefeldin A Induces Apoptosis, Inhibits BCR-ABL Activation, and Triggers BCRABL Degradation in Chronic Myeloid Leukemia K562 Cells.
    Zhang JM; Wang CF; Wei MY; Dong H; Gu YC; Mo XM; Shao CL; Liu M
    Anticancer Agents Med Chem; 2022; 22(6):1091-1101. PubMed ID: 34102989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dibrefeldins A and B, A pair of epimers representing the first brefeldin A dimers with cytotoxic activities from Penicillium janthinellum.
    Zeng F; Chen C; Al Chnani AA; Zhou Q; Tong Q; Wang W; Zang Y; Gong J; Wu Z; Liu J; Wang J; Zhu H; Zhang Y
    Bioorg Chem; 2019 May; 86():176-182. PubMed ID: 30711700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New brefeldin A-cinnamic acid ester derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
    Jiang YY; Wu S; Wu YW; Gao Y; Chong D; Sun C; Wei MY; Gu YC; Shao CL; Gu Y
    Eur J Med Chem; 2022 Oct; 240():114598. PubMed ID: 35849940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents.
    Tian K; Xu F; Gao X; Han T; Li J; Pan H; Zang L; Li D; Li Z; Uchita T; Gao M; Hua H
    Eur J Med Chem; 2017 Aug; 136():131-143. PubMed ID: 28494251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
    Han T; Tian K; Pan H; Liu Y; Xu F; Li Z; Uchita T; Gao M; Hua H; Li D
    Eur J Med Chem; 2018 Apr; 150():53-63. PubMed ID: 29524728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new compound, brefeldin A formylate, from Penicillium sp. strain HLKG-44.
    Zhang HW; Cheng HM; Fang H; Zhao YF; Fang MJ
    J Asian Nat Prod Res; 2009; 11(1):54-7. PubMed ID: 19177238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New analogues of brefeldin A from sediment-derived fungus Penicillium sp. DT-F29.
    Hu ZF; Qin LL; Ding WJ; Liu Y; Ma ZJ
    Nat Prod Res; 2016 Oct; 30(20):2311-5. PubMed ID: 27067647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity.
    El-Damasy AK; Jin H; Seo SH; Bang EK; Keum G
    Eur J Med Chem; 2020 Dec; 207():112710. PubMed ID: 32961435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb.
    Zhang B; Zhang T; Zhang TY; Wang N; He S; Wu B; Jin HX
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penipentenone A and brefeldin A derivatives potently inhibit KRAS mutant cancer cells from an endophytic fungus Penicillium brefeldianum F4a.
    Bai Y; Yi P; Li F; Hu J; Pan H
    Phytochemistry; 2022 Aug; 200():113243. PubMed ID: 35577124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling.
    Hao G; Zhai J; Jiang H; Zhang Y; Wu M; Qiu Y; Fan C; Yu L; Bai S; Sun L; Yang Z
    Biomed Pharmacother; 2020 Feb; 122():109677. PubMed ID: 31810012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating Activity-Guided Strategy and Fingerprint Analysis to Target Potent Cytotoxic Brefeldin A from a Fungal Library of the Medicinal Mangrove
    Wang CF; Ma J; Jing QQ; Cao XZ; Chen L; Chao R; Zheng JY; Shao CL; He XX; Wei MY
    Mar Drugs; 2022 Jun; 20(7):. PubMed ID: 35877725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562).
    Joshi H; Marulkar K; Gota V; Ramaa CS
    Anticancer Agents Med Chem; 2017; 17(4):524-541. PubMed ID: 27291250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic Effects of Some Tetrahydronaphthalene Derivatives on K562 Human Chronic Myelogenous Leukemia Cell Line.
    Koc A; Ozkan T; Hekmatshoar Y; Gurkan-Alp AS; Aktan F; Buyukbingol Z; Sunguroglu A; Buyukbingol E; Karabay AZ
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1924-1930. PubMed ID: 28403785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxic evaluation of acylated brefeldin a derivatives as potential anticancer agents.
    He B; Wang Y; Zheng Y; Chen W; Zhu Q
    Chem Biol Drug Des; 2013 Sep; 82(3):307-16. PubMed ID: 23621857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denbinobin-mediated anticancer effect in human K562 leukemia cells: role in tubulin polymerization and Bcr-Abl activity.
    Huang YC; Guh JH; Teng CM
    J Biomed Sci; 2005; 12(1):113-21. PubMed ID: 15864744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimeric 1,4-benzoquinone Derivatives with Cytotoxic Activities from the Marine-Derived Fungus
    Zhang HM; Ju CX; Li G; Sun Y; Peng Y; Li YX; Peng XP; Lou HX
    Mar Drugs; 2019 Jun; 17(7):. PubMed ID: 31248044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Synthesis of Brefeldin A-Isothiocyanate Derivatives with Selectivity and Their Potential for Cervical Cancer Therapy.
    Wang M; Chen X; Qu Y; Ma Q; Pan H; Li H; Hua H; Li D
    Molecules; 2023 May; 28(11):. PubMed ID: 37298761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.